Contact
Please use this form to send email to PR contact of this press release:
Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study
TO:
Please use this form to send email to PR contact of this press release:
Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study
TO: